NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,100,000 | +33.3% | 4,962,657 | +13.2% | 2.37% | -1.9% |
| Q3 2020 | $2,325,000 | -23.7% | 4,384,199 | -1.4% | 2.42% | -59.0% |
| Q2 2020 | $3,046,000 | -13.4% | 4,447,026 | -5.2% | 5.90% | +58.6% |
| Q1 2020 | $3,518,000 | -52.1% | 4,690,146 | -3.5% | 3.72% | -27.2% |
| Q4 2019 | $7,337,000 | +10.1% | 4,858,889 | +7.9% | 5.11% | -20.9% |
| Q3 2019 | $6,663,000 | +3.9% | 4,502,301 | -9.4% | 6.47% | +46.5% |
| Q2 2019 | $6,413,000 | -45.5% | 4,971,014 | +10.2% | 4.42% | -34.8% |
| Q1 2019 | $11,775,000 | +69.5% | 4,511,504 | +7.2% | 6.77% | +11.0% |
| Q4 2018 | $6,947,000 | +528.7% | 4,210,153 | +1747.2% | 6.10% | +844.4% |
| Q3 2018 | $1,105,000 | -22.6% | 227,919 | +62.8% | 0.65% | -24.5% |
| Q4 2017 | $1,428,000 | -65.4% | 140,000 | -75.2% | 0.86% | -61.6% |
| Q2 2017 | $4,125,000 | – | 565,100 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|